Pharmacological management of pain in chronic pancreatitis

Scottish Medical Journal

Volumn 59, Issue 1, 2014, Pages 71-79

  Paisley, P ^a   Kinsella, J ^b  

^a MONKLANDS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Analgesia; Chronic pain; Pancreatitis

Indexed keywords

ALLOPURINOL; ALPHA TOCOPHEROL; ANALGESIC AGENT; ASCORBIC ACID; ATYPICAL ANTIPSYCHOTIC AGENT; BETA CAROTENE; CHYMOTRYPSIN; DEXTROPROPOXYPHENE; LAXATIVE; METHIONINE; MORPHINE; OCTREOTIDE; OXYCODONE; PARACETAMOL; PLACEBO; SECRETIN; SELENIUM; STEROID; TRAMADOL;

ANALGESIA; ARTICLE; CHRONIC PANCREATITIS; CONSTIPATION; HUMAN; INFLAMMATION; PROSPECTIVE STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT FORM 36; WEIGHT GAIN;

ANALGESIA; CHRONIC PAIN; PANCREATITIS;

ABDOMINAL PAIN; ADMINISTRATION, ORAL; ANALGESICS; ANTIOXIDANTS; ENZYMES; HUMANS; MORPHINE; PAIN MANAGEMENT; PANCREATITIS, ALCOHOLIC; PANCREATITIS, CHRONIC; TRAMADOL;

EID: 84901370529     PISSN: 00369330     EISSN: 20456441     Source Type: Journal    
DOI: 10.1177/0036933013517982     Document Type: Article

References (57)

1. Steer ML, Waxman I and Freedman S. Chronic pancreatitis. N Engl J Med 1995; 332: 1482-1490.
2. Dufour MC and Adamson MD. The epidemiology of alcohol induced pancreatitis. Pancreas 2003; 27: 286-290.
3. Balakrishnan V, Nair P, Radhakrishnan L, et al. Tropical pancreatitis a distinct entity, or merely a type of chronic pancreatitis? Ind J Gastroenterol 2006; 25: 74-81.
4. Kumar P and Clark M. Clinical medicine, 5th ed. London: WB Saunders, 2002.
5. Andren-Sandberg A, Hoem D and Gislason H. Pain management in chronic pancreatitis. Eur J Gastroenterol Hepatol 2002; 14: 957-970.
6. Amman RW, Muellhaupt B and Zurich Pancreatic Study Group. The natural history of pain in alcoholic chronic pancreatitis. Gastroenterology 1999; 116: 1132-1140.
7. Scottish Intercollegiate Guidelines Network. Elliot House, Edinburgh, http://www.sign.ac.uk (accessed January 2011).
8. National Institute for Health and Clinical Excellence. High Holburn, London, http://www.nice.org.uk (accessed January 2011).
9. U.S. National Library of Medicine, National Institute of Health. "PubMed." http://www.ncbi.nlm.nih.gov/pubmed (accessed January 2011).
10. Elsevier BV. "Science Direct." http://www.sciencedirect.com (accessed January 2011).
11. Web MD LLC. "Medscape." http://www.medscape.com/ (accessed January 2011).
12. The Cochrane Collaboration. "The Cochrane Library." http://www.cochrane.org/(accessed January 2011).
13. Ammann RW. A clinically based classification system for alcoholic chronic pancreatitis: summary of an international workshop on chronic pancreatitis. Pancreas 1997; 14: 215-221.
14. Warshaw A, Banks PA and Fernandez del Castillo C. AGA technical review: treatment of pain in chronic pancreatitis. Gastroenterology 1998; 115: 765-776.
15. The Commission on Professional and Hospital Activities. Length of stay by diagnosis and operation. Baltimore, MD: HCIA Inc., 1999, pp.188-192.
16. Di Sebastiano P, di Mola FF, Bockman DE, et al. Chronic pancreatitis: the perspective of pain generation by neuroimmune interaction. Gut 2003; 52: 907-911.
17. Amman RW, Akovbiantz A, Largiader F, et al. Course and outcome of chronic pancreatitis. Gastroenterology 1984; 86: 820-888.
18. Lankisch PG, Seidensticker F, Lohr-Happe A, et al. The course of pain is the same in alcohol and nonalcoholinduced chronic pancreatitis. Pancreas 1995; 10: 338-341.
19. Drewes AM, Krarup AL, Detlefsen S, et al. Pain in chronic pancreatitis: the role of neuropathic pain mechanisms. Gut 2008; 57: 1616-1627.
20. Wilder-Smith CH, Hill L, Osler W, et al. Effect of tramadol and morphine on pain and gastrointestinal motor function in patients with chronic pancreatitis. Dig Dis Sci 1999; 44: 1107-1116.
21. Grond S, Radbruck L, Meuser T, et al. High-dose tramadol in comparison to low-dose morphine for cancer pain relief. J Pain Symptom Manage 1999; 18: 174-179.
22. Andren-Sandberg A. Pain relief in pancreatic disease. Br J Surg 1997; 22: 163-170.
23. Ihse I and Anderson R. The medical management of chronic pancreatitis. Prob Gen Surg 1998; 15: 31-37.
24. Andren-Sandberg A, Zoucas E, Lillo-Gil R, et al. Thoracoscopic splanchnicectomy for chronic, severe pancreatic pain. Sem Laparoscopic Surg 1996; 3: 29-33.
25. European Medicines Agency. Questions and answers on the withdrawal of the marketing authorisations for medicines containing dextropropoxyphene. London, June 2009.
26. Ross FB and Smith MT. The intrinsic antinociceptive effects of oxycodone appear to be J-opioid receptor mediated. Pain 1997; 73: 151-157.
27. Staahl C, Dimcevski G, Andersen SD, et al. Differential effect of opioids in patients with chronic pancreatitis: an experimental pain study. Scand J Gastroenterol 2007; 42: 383-390.
28. Black D and Trevethick M. The kappa opioid receptor is associated with the perception of visceral pain. Gut 1998;43: 312-313.
29. Eisenach JC, Carpenter R and Curry R. Analgesia from a peripherally active kappa-opioid receptor agonist in patients with chronic pancreatitis. Pain 2003; 101: 89-95.
30. Singh VV and Toskes PP. Medical therapy for chronic pancreatitis pain. Curr Gastroenterol Rep 2003; 5: 110-116.
31. Malfertheiner P, Mayer D, Buchler M, et al. Treatment of pain in chronic pancreatitis by inhibition of pancreatic secretion with octreotide. Gut 1995; 36: 450-454.
32. Wallig MA. Xenobiotic metabolism, oxidant stress and chronic pancreatitis. Focus on glutathione. Digestion 1998; 59: 13-24.
33. Morris-Stiff GJ, Bowrey DJ, Oleesky D, et al. The antioxidant profiles of patients with recurrent acute and chronic pancreatitits. Am J Gastroenterol 1999; 94: 2135-2140.
34. Banks PA, Hughes M, Ferrante M, et al. Does allopurinol reduce pain of chronic pancreatitis? Int J Pancreatol 1997; 22: 171-176.
35. Kirk GR, White JS, McKie L, et al. Combined antioxidant therapy reduces pain and improves quality of life in chronic pancreatitis. J Gastroenterol Surg 2006; 10: 499-503.
36. Ware JE Jr and Sherbourne CD. The MOS 36-item shortform health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
37. Bhardwaj P, Garg PK, Maulik SK, et al. A randomized controlled trial of antioxidant supplementation for pain relief in patients with chronic pancreatitis. Gastroenterology 2009; 136: 149-159.
38. The British Thoracic Society. Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma, 3rd ed. London and Edinburgh: British Thoracic Society and Scottish Intercollegiate Guidelines Network, 2009.
39. Cartmell MT, O'Reilly DA, Porter C, et al. A doubleblind placebo-controlled trial of a leukotriene receptor antagonist in chronic pancreatitis in humans. J Hepatobiliary Pancreat Surg 2004; 11: 255-259.
40. Vardanyan M, Melemedjian OK, Price TJ, et al. Reversal of pancreatitis-induced pain by an orally available, small molecule interleukin-6 receptor antagonist. Pain 2010; 151: 257-265.
41. Halfreen H, Pedersen NT and Worning H. Symptomatic effect of pancreatic enzyme therapy in patients with chronic pancreatits. J Gastroenterol 1986; 21: 104-108.
42. Mussner J, Secknus R, Meyer J, et al. Treatment of pain with pancreatic extracts in chronic pancreatitis: results of a prospective placebo-controlled multicentre trial. Digestion 1992; 53: 54-66.
43. Van Hoozen CM, Peeke PG, Taubeneck M, et al. Efficacy of enzyme supplementation after surgery for chronic pancreatitis. Pancreas 1997; 14: 174-180.
44. Sikkens ECM, Cahen DL, Kuipers EJ, et al. Pancreatic enzyme replacement therapy in chronic pancreatitis. Best Pract Res Clin Gastroenterol 2010; 24: 337-347.
45. Ossipov MH, Lai J, King T, et al. Underlying mechanisms of pro-nociceptive consequences of prolonged morphine exposure. Biopolymers 2005; 80: 319-324.
46. Xie JY, Herman DS, Stiller CO, et al. Cholecystokinin in the rostral ventromedial medulla mediates opioidinduced hyperalgesia and antinociceptive tolerance. J Neurosci 2005; 25: 409-416.
47. Shiratori K, Takeuchi T, Satake K, et al. Clinical evaluation of oral administration of a cholecystokinin-A receptor antagonis (loxiglumide) to patients with acute, painful attacks of chronic pancreatitis: a multicentre doseresponse study in Japan. Pancreas 2002; 25: 1-5.
48. Tympner F and Rosch W. The treatment of chronic recurrent pancreatitis with depot secretin a preliminary report. Hepatogastroenterology 1986; 33: 159-162.
49. Draganov P, Patel A, Fazel A, et al. Prospective evaluation of the accuracy of the intraductal secretin stimulation test in the diagnosis of chronic pancreatitis. Clin Gastroenterol Hepatol 2005; 3: 695-699.
50. Frulloni L, Falconi M, Gabbrielli A, et al. Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis 2010; 42: 381-406.
51. Talamini G, Bassi C, Falconi M, et al. Cigarette smoking: an independent risk factor in alcoholic pancreatitis. Pancreas 1996; 12: 131-137.
52. Imoto M and Di Magno EP. Cigarette smoking increases the risk of pancreatic calcification in late-onset but not early-onset idiopathic chronic pancreatitis. Pancreas 2000; 21: 115-119.
53. Chauhan S and Forsmark CE. Pain management in chronic pancreatitis: a treatment algorithm. Pract Res Clin Gastroenterol 2010; 24: 323-335.
54. Meana M, Pruitt SD and Dresselhaus TR. Opioid therapy for chronic pancreatitis: controlling aberrant use through behavioural management. Gen Hosp Psychiatry 1999; 21: 137-140.
55. Ballegaard S, Christophersen SJ, Dawids SG, et al. Acupuncture and transcutaneous electric nerve stimulation in the treatment of pain associated with chronic pancreatitis. A randomised study. Scand J Gastroenterol 1985; 20: 1249-1254.
56. Khan YN, Raza SS and Khan EA. Application of spinal cord stimulation for the treatment of abdominal visceral pain syndromes. Neuromodulation 2005; 8: 16-29.
57. Westlund KN. Gene therapy for pancreatitis pain. Gene Ther 2009; 16: 483-492.